Emerging Technology Centers announced the seven companies that have been accepted into its 2018 Accelerate Baltimore cohort.
Platforms such as Amazon Publishing, Etsy and Instagram have yielded an entire new market of online artists and creators.
Village Capital, a venture capital firm, and Kaiser Permanente have teamed up to address the needs of the aging population in America through a new program called Health: US 2018.
As we celebrate more women becoming medtech leaders and paving the way for innovation, it’s important to remember the many accomplishments women have already made when it comes to the advancement of health and medicine.
Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.
Novavax CEO Stanley Erck said he believes the last quarter was “the most significant in Novavax corporate history.”
The reason? Vaccines, specifically clinical results from the Gaithersburg company’s two lead vaccine programs: RSV for infants via maternal immunization and NanoFlu for seasonal flu.
The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research! Deadline to apply is April 17, 2018.
ETC (The Emerging Technology Centers), Baltimore City’s technology and innovation center and award-winning entrepreneur support organization, was ranked seventh, globally, in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University.
Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease-carrying mosquitoes by listening to their buzz to a plan to release genetically engineered killer mosquitoes to hunt down their disease-carrying wild counterparts.
Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on the treatment of pelvic organ prolapse (POP).